Print
Email
Print Edition StoriesBillerica life sciences materials and supplies company EMD Millipore has acquired cell imaging instrumentation maker Amnis Corp. of Seattle for an undisclosed amount.
According to a release from EMD Millipore, Amnis has 40 employees and reported $14 million in sales in 2010. The company’s technology is used in flow cytometry applications in academic, biotech and pharmaceutical markets, and that will boost EMD Millipore’s product portfolio in flow cytometry, which officials described in the release as an “attractive growth segment.”
The acquisition news follows less than a week after EMD Millipore announced that former Roche executive Robert Yates had been named president of the company. Yates replaces Bernd Reckmann, a Merck KGaA executive who took over as head of the Millipore group after Millipore Corp. was acquired by Merck KGaA last year for $7 billion.
This is the second acquisition for EMD Millipore this year. In March, Merck acquired the microbiology business of Biotest AG of Germany and added it to the operations of EMD Millipore, to boost its business in hygiene monitoring and ready-to-use media products for contamination detection.
The purchase of Amnis is expected to close in the fourth quarter of this year, according to the release.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
